CCR

CC chemokine receptor (CCR) antagonists block G protein-coupled receptors that guide leukocyte migration. CCR2, a receptor for monocyte chemoattractant protein 1 (MCP-1), was cloned in 1994 as two splice variants. CCR5 was identified in 1996 as a fusion cofactor for macrophage-tropic human immunodeficiency virus type 1 (HIV-1). Maraviroc, described in 2005 as a selective small-molecule CCR5 inhibitor, blocks this route of viral entry. Other CCR5 antagonists include vicriviroc malate and aplaviroc, while INCB3344 and MK-0812 target CCR2. Cenicriviroc blocks both CCR2 and CCR5, and GSK2239633A is a CCR4 antagonist for studies of T cell trafficking.

Items 1-25 of 154

  • Maraviroc
    Cat. No.
    A10556

    Maraviroc (UK-427857)

    Synonyms: Celsentri; UK-427857

    Maraviroc is an antiretroviral drug in the CCR5 receptor antagonist class used in the treatment of HIV infection.

    5 mg
    $35.00
    10 mg
    $65.00
    All 8 sizes
  • Vicriviroc Malate
    Cat. No.
    A10971

    Vicriviroc Malate

    Vicriviroc Malate is a second generation orally active CCR5 antagonist, which is also a potent inhibitor of HIV-1 entry into target cells, with a mean IC50 =0.46 nM and IC50 =1~10 nM to HIV isolates (n=52).

    5 mg
    $115.00
    10 mg
    $195.00
    All 5 sizes
  • MK-0812
    Cat. No.
    A11127

    MK-0812

    MK-0812 is a potent and selective CCR2 antagonist with low nM affinity for CCR2 on human monocytes and low nM in the chemotaxis assay. It has good PK profiles in preclinical species and demonstrated efficacy in animal models.

    1 mg
    $175.00
    5 mg
    $180.00
    All 5 sizes
  • INCB 3284 dimesylate
    Cat. No.
    A11104

    INCB 3284 dimesylate

    Synonyms: INCB3284

    INCB 3284 dimesylate is a potent, selective hCCR2 antagonist that exhibits potenct antagonism against monocyte chemoattractant molecule binding to hCCR2 and chemotaxis activity.

    1 mg
    $120.00
    5 mg
    $200.00
    All 6 sizes
  • INCB3344
    Cat. No.
    A11465

    INCB3344

    INCB3344 is a potent, selective and orally bioavailable CCR2 antagonist with IC50 values of 5.1 nM (hCCR2) and 9.5 nM (mCCR2) in binding antagonism and 3.8 nM (hCCR2) and 7.8 nM (mCCR2) in antagonism of chemotaxis activity.

    1 mg
    $55.00
    5 mg
    $145.00
    All 7 sizes
  • GSK2239633A
    Cat. No.
    A12175

    GSK2239633A

    GSK2239633A is a CC-chemokine receptor 4 (CCR4) antagonist, which inhibits the binding of [125I]-TARC to human CCR4 with a pIC50 of 7.96±0.11.

    1 mg
    $25.00
    5 mg
    $70.00
    All 7 sizes
  • Teijin compound 1
    Cat. No.
    A13380

    Teijin compound 1

    Teijin compound 1 is a specific CCR 2 antagonist with IC50s of 24 and 180 nM in chemotaxis and binding assay, respectively.

    1 mg
    $40.00
    5 mg
    $115.00
    All 7 sizes
  • Aplaviroc
    Cat. No.
    A13471

    Aplaviroc

    Synonyms: AK 602; GW 873140; ONO 4128

    Aplaviroc is a CCR5 entry inhibitor developed for the treatment of HIV infection.

    1 mg
    $540.00
    5 mg
    $1,150.00
    All 6 sizes
  • Cenicriviroc
    Cat. No.
    A13643

    Cenicriviroc

    Synonyms: TAK-652; TBR-652

    Cenicriviroc is an experimental drug candidate for the treatment of HIV infection.Cenicriviroc is an inhibitor of CCR2 and CCR5 receptors, allowing it to function as an entry inhibitor which prevents the virus from entering into a human cell.

    1 mg
    $55.00
    2 mg
    $85.00
    All 9 sizes
  • TAK-779
    Cat. No.
    A13846

    TAK-779

    TAK-779 is a novel, potent and selective small-molecule antagonists of CCR5 with the IC50 value of 1.4nM in binding assay.

    1 mg
    $30.00
    5 mg
    $80.00
    All 7 sizes
  • BX471
    Cat. No.
    A14409

    BX471

    BX471 is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1), exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4.

    1 mg
    $25.00
    5 mg
    $75.00
    All 8 sizes
  • PF-4136309
    Cat. No.
    A15127

    PF-4136309

    Synonyms: INCB8761

    PF-4136309 is a potent, selective, and orally bioavailable CCR2 antagonist, with IC50s of 5.2 nM, 17 nM and 13 nM for human, mouse and rat CCR2.

    2 mg
    $35.00
    5 mg
    $60.00
    All 7 sizes
  • RS 504393
    Cat. No.
    A15227

    RS 504393

    RS 504393 is a selective CCR2 chemokine receptor antagonist (IC50 values are 98 nM and > 100 uM for inhibition of human recombinant CCR2b and CCR1 receptors respectively).

    1 mg
    $35.00
    5 mg
    $90.00
    All 7 sizes
  • Vicriviroc maleate
    Cat. No.
    A15276

    Vicriviroc maleate

    Synonyms: Sch-417690; SCH-D

    Vicriviroc maleate is a CCR5 antagonist with IC50 of 0.91 nM in clinical development for the treatment of HIV-1.

    1 mg
    $30.00
    5 mg
    $80.00
    All 7 sizes
  • NSC5844
    Cat. No.
    A15924

    NSC5844

    Synonyms: RE640

    NSC5844 is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic properties.

    5 mg
    $25.00
    10 mg
    $45.00
    All 6 sizes
  • ZK-756326 dihydrochloride
    Cat. No.
    A16363

    ZK-756326 dihydrochloride

    ZK-756326 is a potent, selective and non-peptide CCR8 chemokine receptor agonist. ZK 756326 inhibited the binding of the CCR8 ligand I-309 (CCL1), with an IC(50) value of 1.8 μM.

    5 mg
    $55.00
    10 mg
    $75.00
    All 5 sizes
  • ZK 756326
    Cat. No.
    A16791

    ZK 756326

    ZK 756326 is a nonpeptide agonist specifically targeting the CC chemokine receptor CCR8. It exhibits potent activity in modulating chemokine signaling pathways, making it a valuable tool in studies related to immune response and inflammation. This compound is useful for researchers investigating the role of CCR8 in various biological processes and potential therapeutic applications.

    2 mg
    $30.00
    5 mg
    $40.00
    All 7 sizes
  • Cenicriviroc Mesylate
    Cat. No.
    A17028

    Cenicriviroc Mesylate

    Synonyms: TAK-652 Mesylate; TBR-652 Mesylate

    Cenicriviroc, also known as TAK-652 and TBR-652, is an inhibitor of CCR2 and CCR5 receptors, allowing it to function as an entry inhibitor which prevents the virus from entering into a human cell. CAS: 199673-74-0(LY 334370 hydrochloride); 182563-08-2 (LY 334370 Free Base)

    1 mg
    $70.00
    2 mg
    $100.00
    All 6 sizes
  • BMS-813160
    Cat. No.
    A17040

    BMS-813160

    BMS-813160 is a potent and selective CCR2/CCR5 antagonist with potential immunomodulating and antineoplastic activities.

    1 mg
    $50.00
    2 mg
    $85.00
    All 9 sizes
  • CCR4 antagonist 2
    Cat. No.
    A18471

    CCR4 antagonist 2

    CCR4 antagonist 2 (Compound 31) is a novel potent, orally bioavailable small molecule antagonists of CC chemokine receptor 4 (CCR4) that inhibits Treg trafficking into the Tumor Microenvironment without suppressing the number of Treg in healthy tissues.

    1 mg
    $315.00
    5 mg
    $955.00
    All 6 sizes
  • LMD-009
    Cat. No.
    A18643

    LMD-009

    LMD-009 is a selective CCR8 nonpeptide agonist. LMD-009 mediates chemotaxis, inositol phosphate accumulation, and calcium release in high potencies with EC50s from 11 to 87 nM.

    5 mg
    $345.00
    10 mg
    $645.00
    All 5 sizes
  • PF-04634817
    Cat. No.
    A18659

    PF-04634817

    Synonyms: PF-4634817; PF4634817.

    PF-04634817 is an orally administered CCR2 and CCR5 chemokine receptor antagonist, for the treatment of diabetic nephropathies and diabetic macular oedema.

    1 mg
    $200.00
    5 mg
    $520.00
    All 6 sizes
  • ML604086
    Cat. No.
    A18969

    ML604086

    ML604086 is a selective CCR8 inhibitor, inhibiting CCL1 binding to CCR8 on circulating T-cells. ML604086 inhibits CCL1 mediated chemotaxis and increases in intracellular Ca2+ concentrations.

    1 mg
    $55.00
    5 mg
    $130.00
    All 7 sizes

Items 1-25 of 154

Added to your cart

View Cart Checkout

    Loading...